RXI PHARMACEUTICALS CORP NEW's ticker is RXII and the CUSIP is 74979C303. A total of 24 filers reported holding RXI PHARMACEUTICALS CORP NEW in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $43,000 | +65.4% | 160,446 | +135.3% | 0.00% | – |
| Q4 2015 | $26,000 | -33.3% | 68,186 | -35.5% | 0.00% | -100.0% |
| Q3 2015 | $39,000 | -20.4% | 105,756 | +6.6% | 0.00% | 0.0% |
| Q2 2015 | $49,000 | +226.7% | 99,203 | +382.1% | 0.00% | – |
| Q1 2015 | $15,000 | -77.6% | 20,576 | -50.9% | 0.00% | -100.0% |
| Q4 2014 | $67,000 | -59.9% | 41,874 | -24.7% | 0.00% | -66.7% |
| Q2 2014 | $167,000 | – | 55,599 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|